Breaking Finance News

Zacks Investment Research downgraded CONMED Corporation (NASDAQ:CNMD) to Sell in a report released today.

Only yesterday CONMED Corporation (NASDAQ:CNMD) traded -0.94% lower at $44.65. The company’s 50-day moving average is $41.46 and its 200-day moving average is $42.06. With the last stock price up 6.16% relative to the two hundred day average, compared to the Standard & Poor's 500 Index which has decreased -0.03% over the same time period. 200,347 shares of CNMD traded hands, up from an average trading volume of 153,070

Zacks Investment Research has downgraded CONMED Corporation (NASDAQ:CNMD) to Sell in a report released on 11/28/2016.

Previously on Friday November 18, 2016, Needham reported about CONMED Corporation (NASDAQ:CNMD) raised the target price from $49.00 to $53.00. At the time, this indicated a possible upside of 0.18%.

Recent Performance Chart


CONMED Corporation has price-earnings ratio of 79.73 with a one year low of $35.51 and a one year high of $50.16 and has a market capitalization of $0.

A total of 5 equity analysts have issued a research note on the company. 2 brokers rating the stock a strong buy, 2 firms rating the stock a buy, 3 brokerages rating the company a hold, zero brokerages rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $45.80.

Brief Synopsis About CONMED Corporation (NASDAQ:CNMD)

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Its products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Its product lines consist of orthopedic surgery, general surgery and surgical visualization. Its orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. Its general surgery product line offers a range of products in the areas of advanced surgical, endoscopic technologies and critical care. Its surgical visualization product line offers imaging systems for use in minimally invasive orthopedic and general surgery procedures. Its products are distributed domestically directly to over 6,000 hospitals and other healthcare institutions, as well as through medical specialty distributors.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.